Post by akemp3000 on Jan 10, 2018 7:05:39 GMT -5
The following was a generic but relevant post of a news article found this morning but seems to have been deleted by someone. Reason?
"Blue-chip drugmakers holding $200 billion in cash, mostly overseas, will start investing more of it in mergers and acquisitions after President Trump's tax overhaul slashed the cost of spending the money in the U.S., debt-ratings firm Moody's predicts."
This significant boost to the U.S. economy is not suggesting anything to do with Mannkind Corporation but is interesting as to how it could change the drug industry landscape in the near future. This could fit nicely with the desire of Google, Amazon and other large tech companies to tap further into the healthcare industry.
"Blue-chip drugmakers holding $200 billion in cash, mostly overseas, will start investing more of it in mergers and acquisitions after President Trump's tax overhaul slashed the cost of spending the money in the U.S., debt-ratings firm Moody's predicts."
This significant boost to the U.S. economy is not suggesting anything to do with Mannkind Corporation but is interesting as to how it could change the drug industry landscape in the near future. This could fit nicely with the desire of Google, Amazon and other large tech companies to tap further into the healthcare industry.
